Screening of immunophilin ligands by quantitative analysis of neurofilament expression and neurite outgrowth in cultured neurons and cells. 2007

Danni Liu, and H Beal McIlvain, and Myles Fennell, and John Dunlop, and Andrew Wood, and Margaret M Zaleska, and Edmund I Graziani, and Kevin Pong
Neuroscience Discovery Research, Wyeth Research, Princeton, NJ 08543, United States.

Immunophilins are protein receptors for the immunosuppressant drugs FK506, cyclosporin A (CsA), and rapamycin. Two categories of immunophilins are the FK506-binding proteins (FKBPs), which bind to FK506, rapamycin, and CCI-779 and the cyclophilins, which bind to CsA. Reports have shown that immunophilins are expressed in the brain and spinal cord, are 10-100-fold higher in CNS tissue than immune tissue, and their expression is increased following nerve injury, suggesting that their chemical ligands may have therapeutic utility in the treatment of neurodegenerative diseases. In this study, we report the development and utility of a rapid neurofilament (NF) enzyme-linked immunosorbent assay (ELISA) to quantify neuronal survival and the Cellomics ArrayScan platform to quantify neurite outgrowth following treatment with immunophilin ligands. Cultured neurons or F-11 cells were treated with various immunophilin ligands for 72 or 96h and their promotion of neuronal survival and neurite outgrowth were determined. The results showed that all immunophilin ligands, in a concentration-dependent manner, significantly increased neuronal survival and neurite outgrowth, when compared to control cultures. Taken together, these results demonstrate the potential utility of the neurofilament ELISA and Cellomics ArrayScan platform to efficiently quantify neurotrophic effects of immunophilin ligands on cultured neurons and cell lines.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D016501 Neurites In tissue culture, hairlike projections of neurons stimulated by growth factors and other molecules. These projections may go on to form a branched tree of dendrites or a single axon or they may be reabsorbed at a later stage of development. "Neurite" may refer to any filamentous or pointed outgrowth of an embryonal or tissue-culture neural cell. Neurite

Related Publications

Danni Liu, and H Beal McIlvain, and Myles Fennell, and John Dunlop, and Andrew Wood, and Margaret M Zaleska, and Edmund I Graziani, and Kevin Pong
August 1995, Brain research. Developmental brain research,
Danni Liu, and H Beal McIlvain, and Myles Fennell, and John Dunlop, and Andrew Wood, and Margaret M Zaleska, and Edmund I Graziani, and Kevin Pong
July 2003, Journal of neuroscience research,
Danni Liu, and H Beal McIlvain, and Myles Fennell, and John Dunlop, and Andrew Wood, and Margaret M Zaleska, and Edmund I Graziani, and Kevin Pong
June 2008, Neurochemical research,
Danni Liu, and H Beal McIlvain, and Myles Fennell, and John Dunlop, and Andrew Wood, and Margaret M Zaleska, and Edmund I Graziani, and Kevin Pong
October 2016, Neurochemical research,
Danni Liu, and H Beal McIlvain, and Myles Fennell, and John Dunlop, and Andrew Wood, and Margaret M Zaleska, and Edmund I Graziani, and Kevin Pong
September 2008, Hearing research,
Danni Liu, and H Beal McIlvain, and Myles Fennell, and John Dunlop, and Andrew Wood, and Margaret M Zaleska, and Edmund I Graziani, and Kevin Pong
October 1994, Journal of neuroscience research,
Danni Liu, and H Beal McIlvain, and Myles Fennell, and John Dunlop, and Andrew Wood, and Margaret M Zaleska, and Edmund I Graziani, and Kevin Pong
September 2013, Journal of neural transmission (Vienna, Austria : 1996),
Danni Liu, and H Beal McIlvain, and Myles Fennell, and John Dunlop, and Andrew Wood, and Margaret M Zaleska, and Edmund I Graziani, and Kevin Pong
December 2012, Journal of neurochemistry,
Danni Liu, and H Beal McIlvain, and Myles Fennell, and John Dunlop, and Andrew Wood, and Margaret M Zaleska, and Edmund I Graziani, and Kevin Pong
January 2011, Methods in molecular biology (Clifton, N.J.),
Danni Liu, and H Beal McIlvain, and Myles Fennell, and John Dunlop, and Andrew Wood, and Margaret M Zaleska, and Edmund I Graziani, and Kevin Pong
February 2016, Neural regeneration research,
Copied contents to your clipboard!